Microsoft Corp has made another foray into the biological sciences under a new collaboration with Novartis which will see both companies use artificial intelligence (AI) to energise drug discovery. The partnership, announced on 1 October, will involve joint research on new therapies for macular degeneration and support the development of cell and gene therapies. It will also use AI to explore new designs for future drugs.
